Faculty profile

Vinod Chandran

ResearcherRheumatologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Vinod Chandran

Researcher

Rheumatology

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
129 publications in the last five years, latest in 2026.
Senior (last) author on 31 recent papers, a sign of leading a research group.
Principal investigator on 9 research grants (9 CIHR), most recently in 2026.
Supervisor on 4 trainee awards (4 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

313

Publications

272

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Psoriasis Spondyloarthritis Metabolomics Psoriatic Arthritis Disease Pathways Solid Phase Microextraction Mass Spectrometry Environmental Factors

Latest papers

Immune Mediators in Birdshot Chorioretinopathy: A Systematic Review
Ocular Immunology and Inflammation · 2026
Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis
Journal of Cutaneous Medicine and Surgery · 2026
Response to correspondence on "Psoriatic dactylitis: the association with HLA genetic susceptibility markers" by Kharouf et al.
Annals of the rheumatic diseases · 2026 · senior author

All 313 publications

Latest funding

Are environmental factors affecting psoriatic disease sex-specific? Investigating clinical impact of the microbial metabolites in psoriatic disease
CIHR · 2026 · Nominated PI
$447,525
Interferons and Joint Damage in Psoriatic Arthritis: A Sex-Stratified Analysis
CIHR · 2025 · Supervisor
$5,000
The Role of the Immunometabolism in Spondyloarthritis Drug Response Outcomes
CIHR · 2025 · Supervisor
$120,000

All 18 grants and awards

From the 150 most recent of 313 publications.

Immune Mediators in Birdshot Chorioretinopathy: A Systematic Review

Gao A, Zaslavsky K, Ahmed Y, Radies S, Wong D, Ballios BG, Wright T, Christakis P, Kaplan AJ, Bakshi N

Ocular Immunology and Inflammation20261 citations

DOI: 10.1080/09273948.2026.2655441

Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis

Beecker J, Hong C-H, Veillette H, Vender R, Yeung J, Chandran V, Palmay C

Journal of Cutaneous Medicine and Surgery2026

DOI: 10.1177/12034754251403190

Response to correspondence on "Psoriatic dactylitis: the association with HLA genetic susceptibility markers" by Kharouf et al.

Kharouf F, Abarza VC, Mehta P, Gao S, Ganatra D, Pereira D, Cook RJ, Poddubnyy D, Gladman DD, Chandran V

Annals of the rheumatic diseases2026Senior author

DOI: 10.1016/j.ard.2026.03.031 PMID: 42547202

Preface: Psoriatic Arthritis-evolving paradigms in pathogenesis and clinical management.

Chandran V, Leung YY

Best practice & research. Clinical rheumatology2026First author

DOI: 10.1016/j.berh.2026.102161 PMID: 42142959

T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.

Cheung MW, Choi JD, Stempak JM, Chandran V, Silverberg MS, Watts TH

Journal of immunology (Baltimore, Md. : 1950)2026

DOI: 10.1093/jimmun/vkag173 PMID: 42530982

Do Patients Diagnosed with Psoriatic Arthritis Before or Concurrently With Psoriasis Have Different Disease Phenotypes and Outcomes?

Anacleto-Dabarno M, Kharouf F, Carrizo Abarza V, Mehta P, Gao S, Pereira D, Cook RJ, Poddubnyy D, Chandran V, Gladman DD

The Journal of rheumatology2026

DOI: 10.3899/jrheum.2025-1302 PMID: 42386278

Guardians on call: neutrophils, macrophages and dendritic cells in arthritis pathogenesis.

Sharma N, Bashal J, Bouchefra B, Chandran V, Abdul-Sater A, Oikonomopoulou K

Critical reviews in clinical laboratory sciences2026

DOI: 10.1080/10408363.2025.2539133 PMID: 41013934

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

Mease PJ, Chandran V, Armstrong AW, Blanco R, Ogdie A, Siegel EL, Gottlieb AB, Zeng X, Thaçi D, Kishimoto M, Schulze-Koops H, Kivitz A, Dokoupilová E, Morita A, Ruderman EM, Plewinski M, Wang K, Sardinas C, Vritzali E, Vaile J, Deodhar A

Arthritis & rheumatology (Hoboken, N.J.)2026

DOI: 10.1002/art.70280 PMID: 42473780

Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort.

Lucas Ribeiro A, Al-Zahir Z, Carrizo Abarza V, Maliyar K, Sood S, Bagit A, Sachdeva M, Koppikar S, Gladman DD, Yeung J, Chandran V, Eder L

ACR open rheumatology2026

DOI: 10.1002/acr2.90084 PMID: 42576419

Radiographic sacroiliitis progression in psoriatic arthritis.

Carrizo-Abarza V, Mehta P, Kharouf F, Gao S, Cook RJ, Gladman DD, Chandran V, Poddubnyy D

Rheumatology (Oxford, England)2026

DOI: 10.1093/rheumatology/keag336 PMID: 42384912

Something wrong or missing on this profile? Suggest a correction

Vinod Chandran

Research

Latest papers

Latest funding

Immune Mediators in Birdshot Chorioretinopathy: A Systematic Review

Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis

Response to correspondence on "Psoriatic dactylitis: the association with HLA genetic susceptibility markers" by Kharouf et al.

Preface: Psoriatic Arthritis-evolving paradigms in pathogenesis and clinical management.

T cell immunity to SARS-CoV-2 vaccination in inflammatory bowel disease patients treated with anti-cytokine biologics.

Do Patients Diagnosed with Psoriatic Arthritis Before or Concurrently With Psoriasis Have Different Disease Phenotypes and Outcomes?

Guardians on call: neutrophils, macrophages and dendritic cells in arthritis pathogenesis.

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.

Dual Targeted Therapy as a Treatment Strategy for Refractory Psoriatic Arthritis: Real-World Effectiveness and Safety From a Prospective Cohort.

Radiographic sacroiliitis progression in psoriatic arthritis.

Frequent collaborators

Lihi Eder

Proton Rahman

Igor Jurisica

Richard Cook

Dafna Gladman

Rajiv Gandhi

Nigil Haroon

Vincent Piguet

Kun Liang

Vathany Kulasingam

Anne-Claude Gingras

Zahi Touma

Sasha Bernatsky

Margaret Larche

Jan Dutz

Diane Lacaille

Dianne Mosher

Carter Thorne

Mohit Kapoor

Ronald Vender

Ines Colmegna

Dawn Bowdish

Amanda Dohey

Sowmya Viswanathan

Joan Wither

Liqun Diao

Amit Garg

Louis Flamand

Marie Hudson

Gillian Hawker

Ali Abdul Sater

Vandana Ahluwalia

David Wong

Roman Krawetz

Farheen Mussani

Vipul Jain

Curtis Sobchak

Claire Bombardier

Rosalyn Juergens

Michael Glogauer